Description

Fresenius Medical Care: TDAPA Winds Down After 2026—Can Bundled Payment Offsets and Reignite Plans Blunt the Earnings Shock?

Fresenius Medical Care reported a robust financial performance in 2025, achieving significant strides in profitability, largely driven by strategic initiatives designed to bolster growth and efficiency across its operations. The company’s operational highlights for the year include a significant step-up in group margin to 11.3%, realized through enhanced performances across its three operating segments: Care Delivery, Care Enablement, and Value-Based Care. A key milestone for the year was the launch of the 5008X CAREsystem in select clinics in the United States, part of a broader strategic move to enhance care standards and drive operational efficiencies. This rollout marked a new standard for care delivery, further supported by a steady increase in revenue growth, which reached the upper end of Fresenius Medical Care’s projected outlook for the year.